1. Williams, R. T.: Chemistry of detoxification. In Drugs and the Liver. Gerok and Sickinger, F. K.Schattauer Verlag, Stuttgart, New York, 1975, p. 51–64.
2.
2. Remmer, H.: The role of liver in drug metabolism. Am. J. Med.49: 617–629, 1970.
3.
3. Remmer, H.: Induction of drug metabolizing enzyme system in the liver. Europ. J. Clin. Parmacol. 5. 116–136, 1972.
4.
4. Remmer, H.: Entwicklung des Problems “Teleologische Aspekte der Biotransformation.” In Drugs and the Liver. Gerok and Sickinger, Ed. F. K. Schattauer Verlag, Stuttgart, New York, 1975, pp. 29–37.
5.
5. Fouts, J. R., and Rogers, L. A.: Morphological changes in the liver accompanying stimulation of microsomal drug metabolizing enzyme activity by phenobarbital, chlordane, benzpyrene, or methyl cholanthrene in rats. J. Pharmacol. Exp. Ther.747: 112–120, 1965.
6.
6. Orrenius, S., Ericsson, J. L. E., and Ernster, L.: Phenobarbital-induced synthesis of the microsomal drug-metabolizing enzyme system and its relationship to the proliferation of endoplasmic membranes. J. Cell Biol.25: 627–639, 1965.
7.
7. Ortega, P.: Light and electron microscopy of dichlorophenyltrichloroethane (DDT) poisoning in the rat liver. Lab. Invest.15: 657–679, 1966.
8.
8. Kunz, W., Schaude, G., Schmid, W., and Siess, M.: Lebervergrosserung durch Fremdstoff. Arch. Pharmakol. Exp. Path.254: 470–481, 1966.
9.
9. Herdson, P. B., Garvin, P. J., and Jennings, R. B.: Reversible biological and fine structural changes produced in rat liver by a thiohydantoin compound. Lao. Invest.73: 1014–1031, 1964.
10.
10. Gillette, J. R.: Factors affecting drug metabolism. Ann. N. Y. Acad. Sci.179: 43–66, 1971.
11.
11. Gillette, J. R., Davis, D. C., and Sasame, H. A.: Cytochrome P-450 and its role in drug metabolism. Ann. Rev. Pharmacol.12: 57–84, 1972.
12.
12. Estabrook, R. W., Mason, J. I., Baron, J., Lamberth, D., and Waterman, M.: Drugs, alcohol, and sex hormones: A molecular perspective of the receptivity of cytochrome P-450, Ann. N. Y. Acad. Sci.212: 27–49, 1973.
13.
13. Feinman, L., Rubin, E., and Lieber. Ch.: Adaptation of the liver to drugs. In Liver and Drugs. Orlandi and Jesequel, Eds. Acad. Press, New York, 1972, pp. 41–83.
14.
14. Popper, H.: Structural aspects of hepatic biotransformation. In Drugs and Liver. Gerok and Sickinger, Eds. F. K. Schattauer Verlag, Stuttgart, New York. 1975, pp. 39–50.
15.
15. Levi, A. J., Gatmaitan, Z., and Arias, I. M.: Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in hepatic uptake of bilirubin, sulfobromophthalein, and other anions. J. Clin. Invest.48: 2156–2167, 1969.
16.
16. Fleischner, G., and Arias, I. M.: Recent advances in bilirubin formation, transport, metabolism, and excretion. Am. J. Med.49: 576–589, 1970.
17.
17. Berk, P. D., Bloomer, J. R., and Berlin, N. I.: Y and Z: New terms in the bilirubin equation. N. Eng. J. Med.283: 1166–1167, 1970.
18.
18. Arstila, A. U., Smith, M. A., and Trump, B. F.: Microsomal lipid peroxidation: Morphological characterization. Science175: 530–533, 1972.
19.
19. Tappel, A. L.: Lipid peroxidation damage to cell components. Fed. Proc.32: 1870–1874, 1973.
20.
20. Recknagel, R. O., and Glende, E. A.: Lipid peroxidation in acute carbon tetrachloride liver injury. In Intermediary Metabolism of the Liver. Brown and Harwick, Eds. Charles C. Thomas, Springfield, IL1973, pp. 23–57.
21.
21. Diaz Gomez, M. I., Castro, J. A., De Ferreyra, E. C., D'Acosta, N., and De Castro, C. R.: Irreversible binding of 14C from 14CC14 to liver microsomal lipids and proteins from rats pretreated with compounds altering microsomal mixed-function oxygenase activity. Toxicol. Appl. Pharmacol.25: 534–541, 1973.
22.
22. Dyrszka, H., Salen, G., Zaki, F. G., Chen, T., and Mosbach, H.: Hepatotoxicity in the rhesus monkey treated with chenodeoxycholic acid for 6 months: Biochemical and ultrastructural strudies. Gastroent.70: 93–104, 1976.
23.
23. Popper, H., and Schaffner, F.: Pathophysiology of cholestasis. Human Path.1: 1–24, 1970.
24.
24. Smuckler, E. M., and Arcasoy, M.: Structural and functional changes of the endoplasmic reticulum of hepatic paraenchymal cells. Internat. Rev. Exp. Path.7: 305–320, 1969.
25.
25. Raisfeld, I. H., Bacchin, P., Hutterer, F., and Schaffner, F.: The effect of 3-arnino 1,2,4-triazol on the phenobarbital-induced formation of hepatic microsomal enzymes. Molec. Pharmacol.6: 231–239, 1970.
26.
26. Zaki, F. G.: Effects of steroids on fetal rat liver. Proc. 27th Ann. Meeting of EMSA, 1969, pp. 350-351.
27.
27. Zaki, F. G., and Keysser, C. H.: Electron microscopy of canine hepatic cells in 2-ethyl-2-phenyl butyramide porphyria. Proc. 30th Ann. Meeting of Emsa, 1972, pp. 348-349.
28.
28. Zaki, F. G., and Keysser, C. H.: Ultrastructural and biochemical studies of canine hepatic porphyria induced by 2-ethyl-2-phenyl butyramid (EPB). Gastroent.64: 160, 1973.
29.
29. Zaki, F. G., and Keysser, C. H.: Ultrastructural, biochemical, and immunoelectrophoretic studies of chemically induced hepatic necrosis. Proc. 5th Internat. Assn. Study of the Liver, Versaille (France), 1972, p. 16.
30.
30. Zaki, F. G., Detzi, E., and Keysser, C. H.: Early development of drug-induced hepatic necrosis. Proc. 29th Ann. Meeting of EMSA, 1971, pp. 576-577.
31.
31. Zaki, F. G., and Keysser, G. H.: Experimental hepatic necrosis: Morphologic, biochemical, and immunoelectrophoretic studies. Am. J. Path.78: 11A, 1975.
32.
32. Zaki, F. G.: Lithocholic acid effects on the structure of developing liver cells. Gasfroenr.56: 427, 1969.
33.
33. Zaki, F. G.: Effects of maternal bile stasis on fetal liver. Gasfroenr.56: 1224, 1969.
34.
34. Zaki, F. G., and Keysser, C. H.: Effects of maternal hepato-biliary damage on fetal rat liver. Proc. Internat. Congr. Electron Microscopy, Grenoble (France), 1970, pp. 879-880.
35.
35. Zaki, F. G., and Keysser, C. H.: Detection and characterization of preneoplastic cells in the liver. Gasfroenr, 65: A54/578, 1973.
36.
36. Zaki, F. G., Greenlee, J., and Keysser, C. H.: Fine structure of preneoplastic cells in the liver. Lao. Invest.32: 25, 1975.
37.
37. Zaki, F. G., and Hoffbauer, F. W.: Hepatic ultrastructural changes in chlorpromazine jaundice. J. Appl. Phys.34: 2053, 1963.
38.
38. Zaki, F. G.: Ultrastructure of cholestasis. Medicine45: 537–545, 1966.
39.
39. Gregory, D. H., Zaki, F. G., Sarcosi, A., and Carey, J. B. Jr.: Chronic cholestasis following prolonged tolbutamide administration. Arch. Path.84: 194–201, 1967.